Monoclonal Antibody Therapeutics Market Growth Driven by High Prevalence of Cancer - 0 views
-
ajinkyak on 01 Jul 21High prevalence of cancer is expected to aid in growth of the monoclonal antibody therapeutics market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Monoclonal immunotherapy is a successful form of immunotherapy, which makes use of monoclonal antibodies to bind to a specific antigen in cells which are specific to that disease.